665 results on '"Thambisetty, Madhav"'
Search Results
2. Dual cognitive and mobility impairments and future dementia - Setting a research agenda.
3. Proteome-wide analysis identifies plasma immune regulators of amyloid-beta progression
4. Sex differences in brain protein expression and disease
5. Unbiased proteomics and multivariable regularized regression techniques identify SMOC1, NOG, APCS, and NTN1 in an Alzheimer’s disease brain proteomic signature
6. Longitudinal associations between use of antihypertensive, antidiabetic, and lipid-lowering medications and biological aging
7. Hydroxychloroquine lowers Alzheimer’s disease and related dementias risk and rescues molecular phenotypes related to Alzheimer’s disease
8. A multicentre validation study of the diagnostic value of plasma neurofilament light.
9. Computational Approaches to Assess Abnormal Metabolism in Alzheimer’s Disease Using Transcriptomics
10. Sex-specific genetic predictors of Alzheimer’s disease biomarkers
11. Mitochondrial respiratory chain protein co-regulation in the human brain
12. Lecanemab trial in AD brings hope but requires greater clarity
13. Psychosocial experiences are associated with human brain mitochondrial biology.
14. Sex-Specific Association of Apolipoprotein E With Cerebrospinal Fluid Levels of Tau
15. Longitudinal progression of blood biomarkers reveals a key role of astrocyte reactivity in preclinical Alzheimer's disease
16. Metabolic network failures in Alzheimer's disease: A biochemical road map
17. A Multi-network Approach Identifies Protein-Specific Co-expression in Asymptomatic and Symptomatic Alzheimer’s Disease
18. Plasma p-tau212: antemortem diagnostic performance and prediction of autopsy verification of Alzheimer’s disease neuropathology
19. Plasma biomarkers in relation to spatial distribution of Alzheimer’s disease neuropathology
20. Psychosocial experiences are associated with human brain mitochondrial biology
21. Abnormal brain cholesterol homeostasis in Alzheimer’s disease—a targeted metabolomic and transcriptomic study
22. Individualized clinical management of patients at risk for Alzheimer's dementia
23. Biological sex and DNA repair deficiency drive Alzheimer’s disease via systemic metabolic remodeling and brain mitochondrial dysfunction
24. Shared proteomic effects of cerebral atherosclerosis and Alzheimer’s disease on the human brain
25. Large-scale proteomic analysis of Alzheimer’s disease brain and cerebrospinal fluid reveals early changes in energy metabolism associated with microglia and astrocyte activation
26. Neuropathologic, genetic, and longitudinal cognitive profiles in primary age-related tauopathy (PART) and Alzheimer's disease
27. Neuroimaging and fluid biomarkers of Alzheimer’s disease
28. Serum Proteomic Signatures of Common Health Outcomes among Older Adults.
29. Evidence for brain glucose dysregulation in Alzheimer's disease
30. Plasma based markers of [11C] PiB-PET brain amyloid burden.
31. Longitudinal changes in Alzheimer's‐related plasma biomarkers and brain amyloid
32. Midlife anticholinergic drug use, risk of Alzheimer's disease, and brain atrophy in community-dwelling older adults
33. Dysregulation of lipids in Alzheimer's disease and their role as potential biomarkers
34. Prevalence of dementia subtypes in United States Medicare fee-for-service beneficiaries, 2011–2013
35. Multimodal Imaging and Visual Evoked Potentials Reveal Key Structural and Functional Features That Distinguish Symptomatic From Presymptomatic Huntington's Disease Brain
36. Bile acid synthesis, modulation, and dementia: A metabolomic, transcriptomic, and pharmacoepidemiologic study
37. Lecanemab and APOE Genotyping in Clinical Practice—Navigating Uncharted Terrain
38. Health Conditions Associated with Alzheimer's Disease and Vascular Dementia
39. Dual cognitive and mobility impairments and future dementia ‐ Setting a research agenda
40. Key questions for the evaluation of anti-amyloid immunotherapies for Alzheimer’s disease
41. Studies on the neurotrophic effects of chronic electroconvulsive shock and 5-HT in the adult rat brain
42. State- and trait-dependent associations of vitamin-D with brain function during aging
43. Plasma apolipoprotein J as a potential biomarker for Alzheimer's disease: Australian Imaging, Biomarkers and Lifestyle study of aging
44. Large-scale proteomic analysis of human brain identifies proteins associated with cognitive trajectory in advanced age
45. Correction: Dysregulation of multiple metabolic networks related to brain transmethylation and polyamine pathways in Alzheimer disease: A targeted metabolomic and transcriptomic study
46. Deep proteomic network analysis of Alzheimer’s disease brain reveals alterations in RNA binding proteins and RNA splicing associated with disease
47. Changes in Aβ biomarkers and associations with APOE genotype in 2 longitudinal cohorts
48. Hydroxychloroquine lowers Alzheimer’s disease and related dementias risk and rescues molecular phenotypes related to Alzheimer’s disease
49. Key questions for the evaluation of anti-amyloid immunotherapies for Alzheimer’s disease
50. Publisher Correction: Shared proteomic effects of cerebral atherosclerosis and Alzheimer’s disease on the human brain
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.